Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Breast Neoplasms × Cisplatin × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 12 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Uterine Cervical Neoplasms 2 Urothelial Cancer 2 Urinary Bladder Neoplasms 2 Mesothelioma 2 Carcinoma 2 Various Advanced Cancer 1 Urologic Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Ototoxicity 1 Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer 1 Non Small Cell Lung Cancer NSCLC 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Metastatic Urothelial Cancer 1 Lung Neoplasms 1 Liver Neoplasms 1 Hepatoblastoma 1 Head and Neck Neoplasms 1 Gallbladder Neoplasms 1 Esophageal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Bile Duct Neoplasms 1 Adenocarcinoma of Lung 1 Adenocarcinoma 1

Interventions

Trastuzumab 6 Fulvestrant 6 abemaciclib 5 Capecitabine 5 trastuzumab deruxtecan 4 Paclitaxel 4 eribulin 3 Gemcitabine 3 Docetaxel 3 Cyclophosphamide 3 selpercatinib 2 sacituzumab govitecan 2 ribociclib 2 pertuzumab 2 olaparib 2 exemestane 2 Vinorelbine 2 Letrozole 2 Fluorouracil 2 Epirubicin 2 Doxorubicin 2 Anastrozole 2 Ado-Trastuzumab Emtansine 2 130-nm albumin-bound paclitaxel 2 tucatinib 1 talazoparib 1 palbociclib 1 neratinib 1 larotrectinib 1 inavolisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡